Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Plos One
|
March 6, 2015
Aberrant splicing in transgenes containing introns, exons, and V5 epitopes: lessons from developing an FSHD mouse model expressing a D4Z4 repeat with flanking genomic sequences
Eugénie Ansseau, Jacqueline S Domire, Lindsay M Wallace, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1983
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells
A M Dvorak, H F Dvorak, S P Peters, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 22, 2000
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors
D Feng, J A Nagy, R A Brekken, et al.
The Journal of Cell Biology
|
November 1, 1984
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation
A M Dvorak, I Hammel, E S Schulman, et al.
The Journal of Cell Biology
|
November 1, 1982
Mast cell clones: a model for the analysis of cellular maturation
S J Galli, A M Dvorak, J A Marcum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 1, 2020
RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model
Osasumwen V Aimiuwu, Allison M Fowler, Megha Sah, et al.
The Journal of Experimental Medicine
|
March 1, 1983
Cloned mouse cells with natural killer function and cloned suppressor T cells express ultrastructural and biochemical features not shared by cloned inducer T cells
A M Dvorak, S J Galli, J A Marcum, et al.
Molecular Therapy. Methods & Clinical Development
|
February 2, 2018
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD
Lindsay M Wallace, Nizar Y Saad, Nettie K Pyne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 26, 2025
Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II
Nettie K Pyne, Jessica Bagel, Charles Shyng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2024
Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease
Jessica A Herstine, Pi-Kai Chang, Sergiy Chornyy, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Plos One
|
March 6, 2015
Aberrant splicing in transgenes containing introns, exons, and V5 epitopes: lessons from developing an FSHD mouse model expressing a D4Z4 repeat with flanking genomic sequences
Eugénie Ansseau, Jacqueline S Domire, Lindsay M Wallace, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1983
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells
A M Dvorak, H F Dvorak, S P Peters, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 22, 2000
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors
D Feng, J A Nagy, R A Brekken, et al.
The Journal of Cell Biology
|
November 1, 1984
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation
A M Dvorak, I Hammel, E S Schulman, et al.
The Journal of Cell Biology
|
November 1, 1982
Mast cell clones: a model for the analysis of cellular maturation
S J Galli, A M Dvorak, J A Marcum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 1, 2020
RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model
Osasumwen V Aimiuwu, Allison M Fowler, Megha Sah, et al.
The Journal of Experimental Medicine
|
March 1, 1983
Cloned mouse cells with natural killer function and cloned suppressor T cells express ultrastructural and biochemical features not shared by cloned inducer T cells
A M Dvorak, S J Galli, J A Marcum, et al.
Molecular Therapy. Methods & Clinical Development
|
February 2, 2018
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD
Lindsay M Wallace, Nizar Y Saad, Nettie K Pyne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 26, 2025
Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II
Nettie K Pyne, Jessica Bagel, Charles Shyng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2024
Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease
Jessica A Herstine, Pi-Kai Chang, Sergiy Chornyy, et al.
Page
of 4